Abstract
Gender and environmental factors are known to influence the clinical heterogeneity and outcome of rheumatoid arthritis (RA). Some variables have been suggested to be associated with the severity of the disease, which can be of great value in the correct management of RA patients. The purpose of this study was to investigate the associations among anticyclic citrullinated antibody (anti-CCP2) positivity, extra-articular manifestations (EAM), gender, and tobacco exposure in a Brazilian RA population. We performed a transversal study comprising 156 RA patients which were investigated for EAM, functional class, presence of anti-CCP2, and IgM rheumatoid factor (IgM-RF). The determination of anti-CCP2 was performed using enzyme immunoassay (ELISA) kits and IgM-RF by latex agglutination test. Clinical and demographical data were obtained through review of charts. Anti-CCP positivity intensity was directly correlated with tobacco smoking, sex, and the development of rheumatoid nodules. Intense anti-CCP2 reaction was 19.8-fold higher in females vs. males, 2.7-fold higher in tobacco vs. non-tobacco users, 7.7-fold higher in female vs. male tobacco users, and 5.15-fold higher in patients with rheumatoid nodules. Tobacco smoking, gender, and rheumatoid nodules are significantly correlated with anti-CCP2 positivity in Brazilian RA patients.
Similar content being viewed by others
References
Kvien T, Scherer HU, Burmester GR (2009) Rheumatoid arthritis. In: Bijlsma JWJ (ed) Eular compendium on rheumatic diseases. BMJ, Italy, pp 61–80
Van der Helm-van Mil AHM, Verpoort KN, Breedveld F, Toes REM, Huizinga T (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949–R958
Huizinga TW, Amos CI, Van der Helm-van Mil AHM, Chen W, van Gaalen FA, Jawaheer D et al (2005) Refining the complex rheumatoid arthritis phenotype based on specificity of HLA-DR B1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 52:3433–3438
Klareskog L, Widhe M, Hermansson M, Rönnelid J (2008) Antibodies to citrullinated proteins in arthritis: pathology and promise. Curr Opin Rheumatol 20:300–305
Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F et al (2009) Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 11:R7
Silva AF, Matos AN, Lima AMS, Lima EF, Gaspar AP, Braga JAF et al (2006) Valor Diagnóstico do Anticorpo Antipeptídeo Citrulinado Cíclico na Artrite Reumatóide. Rev Bras Reumatol 46:174–180
Mota LMH, Santos Neto LL, Burlingame R, Laurindo IMM (2009) Comportamento distinto dos sorotipos do fator reumatoide em avaliação seriada de pacientes com artrite reumatóide inicial. Rev Bras Reumatol 49:223–235
Jawaheer D, Lum RF, Gregersen PK, Criswell LA (2006) Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheum 54:3087–3094
Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases—2008. Isr Med Assoc J 10:13–19
Onozaki K (2009) Etiological and biological aspects of cigarette smoking in rheumatoid arthritis. Inflamm Allergy Drug Targets 8:364–368
Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J et al (2006) A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 54:38–46
Lee H-S, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H et al (2007) Interaction between smocking, the shared epitope and anti-cyclic citrullinated peptide. Arthritis Rheum 56:1745–1753
Mikuls TR, Hughes LB, Westfall AO, Holers VM, Parrish L, van der Heijde D et al (2008) Cigarette smoking, disease severity, and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis 67:1529–1534
De Ricke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L et al (2004) Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra articular manifestations. Ann Rheum Dis 63:1587–1593
Korkmaz C, Us T, Kaşifoğlu T, Akgün Y (2006) Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem 39:961–965
Kim S-K, Park S-H, Shin I-H, Choe J-Y (2008) Anti-cyclic citrullinated peptide antibody, smocking, alcohol consumption and disease duration as risk factors for extra-articular manifestations in Korean patients with rheumatoid arthritis. J Rheumatol 35:995–1001
Turesson C, Jakobson LTH (2005) Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 33:65–72
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Daniel T (2008) Sjögren’s syndrome. In: Klippel JH, Stone JH, Crofford LJ, White PH (eds) Primer on rheumatic diseases. Springer, New York, pp 389–397
Klippel JH, Dieppe PA (1998) Selected measures for outcome assessment of rheumatic diseases. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby, London, pp S-A:1–S-A:12
Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieude P et al (2008) Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 67:466–470
MacKay J, Crofton J (1996) Tobacco and the developing world. In: Doll R, Crofton J (eds) Tobacco and health. Royal Society of Medicine, London
Skare TL, Silva MBG, Silva MG, Gomes F, Rumor C, Giacomini G (2002) Rheumatoid factor and tobacco exposure. Braz Arch Biol Technol 45:203–207
Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH (2009) Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 68:201–208
Manavalan JS, Kirman I, Zhao K, Weksler ME (1998) Aging and autoimmunity. In: Rose NR, Mackay IR (eds) The autoimmune diseases. Academic, San Diego, pp 783–794
Cimmino MA, Salvarani C, Macchioni P, Montecucco C, Fossaluzza V, Mascia MT (2000) Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 19:213–217
Martinéz-Castro E, Olivé Marqués A, Bonet Llorach M, Carbonell Abeló J, Cobo Valeri E, Juncà Valdor S (1990) Rheumatoid arthritis and Sjögren syndrome: special reference to the course time of rheumatoid arthritis. Med Clin Barc 94:655–659
Lee AN, Beck CE, Hall M (2008) Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review. Clin Lab Sci 21:15–18
Acknowledgments
We wish to thank the Fundação Araucária and Biometrix Diagnóstica for partial sponsorship of the present study.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goeldner, I., Skare, T.L., de Messias Reason, I.T. et al. Association of anticyclic citrullinated peptide antibodies with extra-articular manifestations, gender, and tabagism in rheumatoid arthritis patients from southern Brazil. Clin Rheumatol 30, 975–980 (2011). https://doi.org/10.1007/s10067-011-1711-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1711-8